Deborah A. Lew‐Kaya

Author

Deborah A. Lew‐Kaya

Allergan (Ireland)

Also Known As

D A Lew-Kaya, D LEWKAYA, D. Lew-Kaya, Deborah A Lew-Kaya, Deborah A. Lew-Kaya, Deborah A. Lew‐Kaya, Deborah Lew-Kaya

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Allergan (Ireland)University of California, Irvine University of Utah University of Michigan The University of Texas Health Science Center at Houston

About

Deborah A. Lew‐Kaya is an author at Allergan (Ireland) specializing in medicine, dermatology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	844
2	Pharmacology	7	7	610
3	Scleroderma	3	3	404
4	Wound Healing	3	3	364
5	Health Sciences	2	2	150

Deborah A. Lew‐Kaya

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect Gerald D. Weinstein, Gerald G. Krueger, Nicholas J. Lowe, Journal of the American Academy of Dermatology Tazarotene GelTherapeutic EffectOphthalmologyMedicineTopical Drug	1997	186
Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks Gerald D. Weinstein, John Koo, Gerald G. Krueger, Journal of the American Academy of Dermatology Tazarotene Creams 0.05MedicinePsoriatic ArthritisClinical DermatologyTazarotene Cream	2003	135
Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis Mark Lebwohl, Debra Breneman, Bernard S. Goffe, Journal of the American Academy of Dermatology Corticosteroid CreamMedicinePsoriatic ArthritisPlaque PsoriasisClinical Dermatology	1998	135
Response of psoriasis to a new topical retinoid, AGN 190168 Teresa Esgleyes-Ribot, Roshantha A.S. Chandraratna, Deborah A. Lew‐Kaya, Journal of the American Academy of Dermatology OphthalmologyMedicineNew Topical RetinoidClinical DermatologySkin Pharmacology	1994	134
Tazarotene Cream for the Treatment of Facial Photodamage Sewon Kang, Nicholas J. Lowe, J.‐P. Ortonne, Archives of Dermatology	2001	112
Tazarotene plus UVB phototherapy in the treatment of psoriasis John Koo, Nicholas J. Lowe, Deborah A. Lew‐Kaya, Journal of the American Academy of Dermatology MedicinePhotocarcinogenesisUvb PhototherapyPhototoxicityClinical Dermatology	2000	100
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Tania J. Phillips, Alice B. Gottlieb, Nicholas J. Lowe, PubMed	2002	97
Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Alan R. Shalita, Dan K. Chalker, R F Griffith, PubMed Tazarotene GelOphthalmologyAcne VulgarisPharmacologyTopical Drug	1999	78
The Safety and Efficacy of Tazarotene Gel, a Topical Acetylenic Retinoid, in the Treatment of Psoriasis Gerald G. Krueger, Lynn A. Drake, Peter M. Elias, Archives of Dermatology	1998	73
A multicenter, randomized, double-blind trial of tazarotene 0.1% cream in the treatment of photodamage Sewon Kang, Gerald G. Krueger, Emil Tanghetti, Journal of the American Academy of Dermatology PhotochemistryPhotodynamic TherapyMedicineDouble-blind TrialPhototoxicity	2005	50

Page 1